The hallucinogens and the inhalants.
The hallucinogenic drugs represent a recurrent outbreak pattern with each generation or two seeming to rediscover their ego-dissolving effects. The inhalants produce a short-lived intoxication with certain volatile solvents affecting specific organ systems.
D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine / Q000494:pharmacology; D015104:3,4-Methylenedioxyamphetamine / Q000494:pharmacology; D000293:Adolescent; D013759:Dronabinol / Q000494:pharmacology; D006213:Hallucinogens / Q000494:pharmacology; D006801:Humans; D007649:Ketamine / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008635:Mescaline / Q000494:pharmacology; D004130:N,N-Dimethyltryptamine / Q000494:pharmacology; D010622:Phencyclidine / Q000494:pharmacology; D011562:Psilocybin / Q000494:pharmacology; D012997:Solvents / Q000494:pharmacology; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy
D006213:Hallucinogens; D012997:Solvents; D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine; D011562:Psilocybin; D015104:3,4-Methylenedioxyamphetamine; D007649:Ketamine; D013759:Dronabinol; D008238:Lysergic Acid Diethylamide; D010622:Phencyclidine; D008635:Mescaline; D004130:N,N-Dimethyltryptamine